- Nigerian, Japanese Firms Partner on Pharmaceutical Innovation
Fidson Healthcare Plc has announced the execution of a strategic alliance with a Japanese healthcare company, Ohara Pharmaceutical Company Limited to drive innovation in the pharmaceutical industry.
Fidson said in a statement that the alliance was a result of its recent rights issue, which saw Ohara’s shareholding in the company increase to 21.57 per cent.
According to the statement, the strategic alliance is aimed at supporting Fidson in fulfilling its commitment to provide the Nigerian market with the latest healthcare products and services.
The statement read in part, “Ohara, being a major player in the Asian pharmaceutical market, will bring cutting edge technology and innovation through technology transfer, expertise, and knowledge sharing to enhance Fidson’s excellence and ascendency in the Nigerian pharma space.
“The alliance holds promise as a significant growth driver for both companies, particularly as a major factor for the development of local pharmaceutical manufacturing in Nigeria.”
Fidson said the significance of the collaboration to the emerging Nigerian healthcare system was evidently enormous, given the rapid population growth, the healthcare state and the living standards of the larger population in the country.
It said given the growing population, there was no doubt that Nigeria was in urgent need of a rapid improvement in the standard of healthcare delivery.
“This can only be accelerated through modernisation and technological intervention, which the alliance with Ohara aims to deliver,” the statement added.
